Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16816014rdf:typepubmed:Citationlld:pubmed
pubmed-article:16816014lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16816014lifeskim:mentionsumls-concept:C0004930lld:lifeskim
pubmed-article:16816014lifeskim:mentionsumls-concept:C0497327lld:lifeskim
pubmed-article:16816014lifeskim:mentionsumls-concept:C1457887lld:lifeskim
pubmed-article:16816014lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:16816014lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:16816014lifeskim:mentionsumls-concept:C0527316lld:lifeskim
pubmed-article:16816014pubmed:issue7lld:pubmed
pubmed-article:16816014pubmed:dateCreated2006-7-3lld:pubmed
pubmed-article:16816014pubmed:abstractTextThe objective of this study was to conduct exploratory analyses of data pertaining to the efficacy of donepezil treatment of patients with severe behavioral disturbances. Preliminary studies suggest that cholinesterase inhibitors, including donepezil, may reduce behavioral disturbances in patients with Alzheimer disease (AD). Most patients included in clinical trials have had low levels of psychopathology at baseline, and the effect of cholinesterase inhibitors on patients with more severe behavioral disturbances is unknown. The authors report the effects of donepezil on behavioral disturbances in patients with relatively severe psychopathology at baseline.lld:pubmed
pubmed-article:16816014pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16816014pubmed:languageenglld:pubmed
pubmed-article:16816014pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16816014pubmed:citationSubsetIMlld:pubmed
pubmed-article:16816014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16816014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16816014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16816014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16816014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16816014pubmed:statusMEDLINElld:pubmed
pubmed-article:16816014pubmed:monthJullld:pubmed
pubmed-article:16816014pubmed:issn1064-7481lld:pubmed
pubmed-article:16816014pubmed:authorpubmed-author:CummingsJeffr...lld:pubmed
pubmed-article:16816014pubmed:authorpubmed-author:ZhangRichardRlld:pubmed
pubmed-article:16816014pubmed:authorpubmed-author:McRaeThomasTlld:pubmed
pubmed-article:16816014pubmed:authorpubmed-author:Donepezil-Ser...lld:pubmed
pubmed-article:16816014pubmed:issnTypePrintlld:pubmed
pubmed-article:16816014pubmed:volume14lld:pubmed
pubmed-article:16816014pubmed:ownerNLMlld:pubmed
pubmed-article:16816014pubmed:authorsCompleteYlld:pubmed
pubmed-article:16816014pubmed:pagination605-12lld:pubmed
pubmed-article:16816014pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:16816014pubmed:meshHeadingpubmed-meshheading:16816014...lld:pubmed
pubmed-article:16816014pubmed:meshHeadingpubmed-meshheading:16816014...lld:pubmed
pubmed-article:16816014pubmed:meshHeadingpubmed-meshheading:16816014...lld:pubmed
pubmed-article:16816014pubmed:meshHeadingpubmed-meshheading:16816014...lld:pubmed
pubmed-article:16816014pubmed:meshHeadingpubmed-meshheading:16816014...lld:pubmed
pubmed-article:16816014pubmed:meshHeadingpubmed-meshheading:16816014...lld:pubmed
pubmed-article:16816014pubmed:meshHeadingpubmed-meshheading:16816014...lld:pubmed
pubmed-article:16816014pubmed:meshHeadingpubmed-meshheading:16816014...lld:pubmed
pubmed-article:16816014pubmed:meshHeadingpubmed-meshheading:16816014...lld:pubmed
pubmed-article:16816014pubmed:meshHeadingpubmed-meshheading:16816014...lld:pubmed
pubmed-article:16816014pubmed:meshHeadingpubmed-meshheading:16816014...lld:pubmed
pubmed-article:16816014pubmed:meshHeadingpubmed-meshheading:16816014...lld:pubmed
pubmed-article:16816014pubmed:meshHeadingpubmed-meshheading:16816014...lld:pubmed
pubmed-article:16816014pubmed:meshHeadingpubmed-meshheading:16816014...lld:pubmed
pubmed-article:16816014pubmed:meshHeadingpubmed-meshheading:16816014...lld:pubmed
pubmed-article:16816014pubmed:meshHeadingpubmed-meshheading:16816014...lld:pubmed
pubmed-article:16816014pubmed:meshHeadingpubmed-meshheading:16816014...lld:pubmed
pubmed-article:16816014pubmed:year2006lld:pubmed
pubmed-article:16816014pubmed:articleTitleEffects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders.lld:pubmed
pubmed-article:16816014pubmed:affiliationDepartment of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. jcummings@mednet.ucla.edulld:pubmed
pubmed-article:16816014pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16816014pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:16816014pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:16816014pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16816014lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16816014lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16816014lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16816014lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16816014lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16816014lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16816014lld:pubmed